The Application of Long-Acting and Short-Acting Forms of Gonadotrophin-Releasing Hormone Agonists in Long Protocol of IVF/ICSI Cycles

LIU Jingyu,SUN Haixiang,WANG Bin

DOI: https://doi.org/10.3969/j.issn.1003-6946.2012.05.026

2012-01-01

Abstract:Objective:To explore the effects of long-acting and short-acting GnRH agonist on the clinical outcomes of IVF/ICSI long protocol cycles.Methods:Luteal-phase downregulation long protocol was applied for normal ovulation patients,oral contraceptive pills pretreatment long protocol was applied for anovulation patients.Patients were divided into two groups according to using long-acting or short-acting GnRH agonist,the parameters during treatment cycles were compared between the two groups.Results:The doses and the duration of GnRH-a in long-acting GnRH-a group were more or longer than those in short-acting group(P0.05,P0.01),also the level of progesterone on HCG injection day in long-acting group was much higher than that in short-acting group(P0.05,P0.01).The clinical pregnant rate and embryo implantation rate in long-acting group were also lower than those in short-acting group(P0.05).In both of the long protocols,the cycle distributions according to the diameter of dominant follicle(≥18 mm~≤20 mm,20 mm~≤22 mm or 22 mm) between long-acting and short-acting GnRH-a groups were no statistical differences(P0.05).Conclusions:Long-acting GnRH agonist in long protocols will increase the Gn doses and the level of progesterone,so this may cause bad effect on pregnancy outcome by decreasing the pregnancy and implantation rate.